These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 85550)

  • 21. Hormonal status in prostatic disease.
    Frick J; Bartsch G
    Prog Clin Biol Res; 1976; 6():143-58. PubMed ID: 66687
    [No Abstract]   [Full Text] [Related]  

  • 22. Androgens in patients with benign prostatic hyperplasia before and after prostatectomy.
    Vermeulen A; De Sy W
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1250-4. PubMed ID: 63468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hormonal environment and antiandrogenic treatment in benign prostatic hypertrophy].
    Katayama T; Umeda K; Kazama T
    Hinyokika Kiyo; 1986 Nov; 32(11):1584-9. PubMed ID: 2435122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum sex hormones and measures of benign prostatic hyperplasia.
    Roberts RO; Jacobson DJ; Rhodes T; Klee GG; Leiber MM; Jacobsen SJ
    Prostate; 2004 Oct; 61(2):124-31. PubMed ID: 15305335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The hypothalamic-hypophyseal-gonadal axis in patients undergoing chronic haemodialysis.
    Rosa CD; Cascone C; Antonucci F; Foresta C; Mastrogiacoma I
    Proc Eur Dial Transplant Assoc; 1977; 14():565-7. PubMed ID: 600971
    [No Abstract]   [Full Text] [Related]  

  • 26. [Determination of LH and FSH levels before and after prostatic adenomectomy (author's transl)].
    Fontana D; Isaia GC; Fasolis G; Bertagna A; Borgno M; Molinatti GM
    J Urol Nephrol (Paris); 1979; 85(7-8):479-84. PubMed ID: 93649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radical prostatectomy: influence on serum and urinary androgen levels.
    Olsson M; Ekström L; Schulze J; Kjellman A; Akre O; Rane A; Gustafsson O
    Prostate; 2010 Feb; 70(2):200-5. PubMed ID: 19760638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hormone concentration, metabolic disorders and immunoexpression of androgen and estrogen-alpha receptors in men with benign prostatic hyperplasia and testosterone deficiency syndrome.
    Ryl A; Rotter I; Slojewski M; Dolegowska B; Grabowska M; Baranowska-Bosiacka I; Laszczynska M
    Folia Histochem Cytobiol; 2015; 53(3):227-35. PubMed ID: 26400665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different reactivity of the hypothalamo-pituitary-gonadal-axis in depression and normal controls.
    Rupprecht R; Rupprecht C; Rupprecht M; Noder M; Schwarz W
    Pharmacopsychiatry; 1988 Nov; 21(6):438-9. PubMed ID: 3149753
    [No Abstract]   [Full Text] [Related]  

  • 30. [Changes in the function of the hypothalamic-hypophyseal-gonadal axis in the male with hepatic cirrhosis].
    Conde Yagüe R; Gutiérrez-Cortines Corral MD; Ledesma Castaño F; González Coterillo T; Ortiz Ortiz M; Ramos Fernández R; Leno Valencia L
    Rev Clin Esp; 1985 Jun; 177(2):53-6. PubMed ID: 3931186
    [No Abstract]   [Full Text] [Related]  

  • 31. Relationship between serum testosterone and measures of benign prostatic hyperplasia in aging men.
    Liu CC; Huang SP; Li WM; Wang CJ; Chou YH; Li CC; Huang CH; Wu WJ
    Urology; 2007 Oct; 70(4):677-80. PubMed ID: 17991536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of antiestrogen, antiandrogen, and the prolactin inhibitor 2 bromo-alpha-ergocriptine on the stromal tissue of human benign prostatic hyperplasia. Correlation of stereological data and plasma hormones.
    Bartsch G; Oberholzer M; Rohr HP
    Invest Urol; 1981 Jan; 18(4):308-12. PubMed ID: 6161105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Testosterone levels in benign prostatic hyperplasia: sexual function and response to therapy with dutasteride.
    Swerdloff R
    Nat Clin Pract Urol; 2006 Oct; 3(10):528-9. PubMed ID: 17031376
    [No Abstract]   [Full Text] [Related]  

  • 34. High-grade prostate cancer is associated with low serum testosterone levels.
    Schatzl G; Madersbacher S; Thurridl T; Waldmüller J; Kramer G; Haitel A; Marberger M
    Prostate; 2001 Apr; 47(1):52-8. PubMed ID: 11304729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of nafarelin acetate, a luteinizing-hormone-releasing hormone agonist, on benign prostatic hyperplasia.
    Peters CA; Walsh PC
    N Engl J Med; 1987 Sep; 317(10):599-604. PubMed ID: 2441256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Some aspects of hypothalamo-hypophyseal-gonadal axis function in the testicular feminization syndrome].
    Massobrio M; Chiara G; Ottone P
    Minerva Ginecol; 1978 Mar; 30(3):125-9. PubMed ID: 662189
    [No Abstract]   [Full Text] [Related]  

  • 37. Hormonal predictors of prostate cancer.
    Sofikerim M; Eskicorapci S; Oruç O; Ozen H
    Urol Int; 2007; 79(1):13-8. PubMed ID: 17627161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostate carcinoma with peripheral metastases after prostatectomy and low levels of serum prostate specific antigen.
    Seven B; Varoglu E; Cayir K; Sahin A; Kantarci M
    Hell J Nucl Med; 2008; 11(1):53-4. PubMed ID: 18392233
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hypothalamo-hypophyseal-gonadal axis in the Prader-Labhardt-Willi syndrome].
    Zappulla F; Salardi S; Tassinari D; Villa MP; Fréjaville E; Ventura D; Montanari P
    Minerva Pediatr; 1981 Mar; 33(5):201-4. PubMed ID: 6787402
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment with D-Trp-6-LHRH. Plasma levels and gonadotropic response].
    Lahlou N; Duchier J; Feinstein MC; Mauvernay RY; Roger M; Schally AV
    Pathol Biol (Paris); 1984 Oct; 32(8):906-8. PubMed ID: 6209605
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.